Literature DB >> 1577301

Topical and intravenous gentamicin in traumatically lacerated eyes.

M O Yoshizumi1, M J Leinwand, J Kim.   

Abstract

Intravenous or topical gentamicin may be the initial mode of treatment for lacerated or ruptured eyes by emergency room physicians while awaiting ophthalmic consultation and surgical repair. The purpose of this study was to determine the possibility of having retinotoxic intravitreal gentamicin concentrations in experimentally lacerated rabbit eyes treated with either intravenous or topical gentamicin separately or in combination with each other. Nontoxic concentrations of gentamicin were found in the vitreous bodies by all routes of drug administration. After 3 h intravitreal concentrations of gentamicin were: 0.20-0.30 microgram/ml when treated intravenously, 0-2.9 micrograms/ml when treated topically, and 0.20-0.51 microgram/ml when treated both intravenously and topically. While the upper range of topically applied gentamicin concentrations (2.9 micrograms/ml) is therapeutic for some pathogens, the wide range of intravitreal concentrations (0-2.9 micrograms/ml) achieved does not indicate that topically applied gentamicin with or without intravenously administered gentamicin can reliably achieve therapeutic concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577301     DOI: 10.1007/bf00164659

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  Ocular penetration of topically applied gentamicin.

Authors:  B Ellerhost; B Golden; N Jarudi
Journal:  Arch Ophthalmol       Date:  1975-05

2.  Recent microbiological studies with gentamicin.

Authors:  J A Waitz; M J Weinstein
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

3.  Gentamicin: in vitro studies.

Authors:  W M Kirby; H C Standiford
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  Penetration of gentamicin into the aphakic eye.

Authors:  G A Peyman; D R May; P I Homer; R T Kasbeer
Journal:  Ann Ophthalmol       Date:  1977-07

5.  Retinal toxicity of intravitreal gentamicin. An electron microscopic study.

Authors:  D J D'Amico; J Libert; K R Kenyon; L A Hanninen; L Caspers-Velu
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-05       Impact factor: 4.799

6.  Antibiotic prophylaxis in penetrating injuries of the eye.

Authors:  A B Parunović; B A Popović
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-05-26

7.  Experimental intravitreal gentamicin.

Authors:  I G Zachary; R K Forster
Journal:  Am J Ophthalmol       Date:  1976-10       Impact factor: 5.258

8.  The penetration of gentamicin into the vitreous humor in man.

Authors:  E Rubinstein; J Goldfarb; G Keren; M Blumenthal; G Treister
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-05       Impact factor: 4.799

9.  Comparative toxicity of intravitreal aminoglycoside antibiotics.

Authors:  D J D'Amico; L Caspers-Velu; J Libert; E Shanks; M Schrooyen; L A Hanninen; K R Kenyon
Journal:  Am J Ophthalmol       Date:  1985-08-15       Impact factor: 5.258

  9 in total
  1 in total

1.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.